CHICAGO - Radiation received by other organs during a mammogram is very low and does not present an increased cancer risk, researchers found.
CHICAGO - Mammograms are a fact of life for many women in America. Unfortunately, so are daytime talk shows. When one show suggested that errant radiation from mammograms may cause cancer in other parts of the body, women blanched and doctors cringed.
But a new study presented Tuesday at RSNA 2012 found that radiation received by other organs during a mammogram is very low and does not present an increased cancer risk.
“The risk of cancer to nearby organs is indistinguishable from incidence of cancer due to other sources. The benefits of screening mammography greatly outweigh the scatter radiation to these organs,” said Alison L. Chetlen, DO, who led the study.
Chetlen and colleagues at Penn State Hershey Medical Center set out to study the radiation received by the thyroid, salivary gland, lenses of the eyes, sternum and uterus during a typical mammography and compare it to background radiation that all humans receive simply from living on Earth.
During a mammogram, some X-rays in fact do “scatter” from the beam directed at the breast, she said. While this radiation is weakened, some women became concerned that radiosensitive areas like the thyroid might absorb these extraneous rays and cause cancer later in life. They prefer to wear collars to shield them from the radiation.
As part of the study, 207 women were fitted with six tiny radiation detectors called dosimeters. Smaller than the size of the penny, these detectors measured the amount of ionizing radiation present on the skin while undergoing a two-view mammography screening. The detectors were evaluated by a health physicist and organ dose was calculated based on the skin dose and the average tissue thickness between the skin and the organ.
Researchers found that the average dose received during a screening is miniscule, less than 2 percent than the amount received annually through background radiation.
The absorbed radiation measurements were taken in milligray, mGy. The uterus, for instance, received .002 mGy of radiation during the screening. By comparison, the annual natural background dose is 3.1 millisieverts, mSv, equivalent in this study to mGy. Therefore, “screening mammography can be performed during pregnancy with no increased risk to the fetus,” Chetlen advised.
As for the thyroid, Chetlen posits that thyroid shields are unnecessary and perhaps even detrimental to the mammography process. “The thyroid gland is not radiosensitive in the age group undergoing screening mammography,” she pointed out. “We know that the thyroid collar can get in the way, so much so that if, depending on the heaviness of the patient, it can override the upper inner breast which could obscure significant findings of breast cancer. It could reduce the quality of the image, it may get in the way of the image, causing a shadow or artifact, and we'd have to retake the view.”
Chetlen noted that these are not exact measurements, but more a guideline to be considered by physicians concerning mammography radiation levels.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.